PRMT5 and systemic sclerosis: When anti-PRMT5 antibody seropositivity was defined as OD 450 nm values above the 99th percentile of the healthy controls, none of healthy control subject (%) and 48.5% of SSc patients exhibited seropositivity (p < 0.0001, Fig. 1C).